141 related articles for article (PubMed ID: 30744447)
21. Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon.
Ellis M; Mills AK
Intern Med J; 2015 Mar; 45(3):358-9. PubMed ID: 25735582
[No Abstract] [Full Text] [Related]
22. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
23. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon.
Al Bahar S; Pandita R; Nath SV
Int J Gynaecol Obstet; 2004 Jun; 85(3):281-2. PubMed ID: 15145269
[No Abstract] [Full Text] [Related]
24. Imatinib: a review of its use in chronic myeloid leukaemia.
Moen MD; McKeage K; Plosker GL; Siddiqui MA
Drugs; 2007; 67(2):299-320. PubMed ID: 17284091
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy: part of life in chronic myelogenous leukemia.
Law AD; Dong Hwan Kim D; Lipton JH
Leuk Lymphoma; 2017 Feb; 58(2):280-287. PubMed ID: 27389567
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
Iqbal J; Ali Z; Khan AU; Aziz Z
Leuk Lymphoma; 2014 Sep; 55(9):2109-13. PubMed ID: 24237577
[TBL] [Abstract][Full Text] [Related]
27. Generic imatinib in the treatment of chronic myeloid leukemia: two years' experience in Latvia.
Lejniece S; Udre I; Rivkina A
Exp Oncol; 2017 Jul; 39(2):151-154. PubMed ID: 29483494
[TBL] [Abstract][Full Text] [Related]
28. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.
Sazawal S; Chikkara S; Singh K; Chaubey R; Chandra D; Mishra P; Mahapatra M; Seth T; Saxena R
Ann Diagn Pathol; 2017 Apr; 27():24-27. PubMed ID: 28325357
[TBL] [Abstract][Full Text] [Related]
29. How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience.
Ferrero D; Cerrano M; Crisà E; Aguzzi C; Giai V; Boccadoro M
Br J Haematol; 2017 Feb; 176(4):669-671. PubMed ID: 26914729
[No Abstract] [Full Text] [Related]
30. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
Mesquita MM; Pestana A; Mota A
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
[No Abstract] [Full Text] [Related]
31. Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia.
Giona F; Malaspina F; Putti MC; Ladogana S; Mura R; Burnelli R; Vacca N; Rizzo L; Bianchi S; Moleti ML; Testi AM; Biondi A; Locatelli F; Saglio G; Foà R
Br J Haematol; 2020 Mar; 188(6):e101-e105. PubMed ID: 32087030
[No Abstract] [Full Text] [Related]
32. Chronic Myeloid Leukemia--Prognostic Value of Mutations.
Kaleem B; Shahab S; Ahmed N; Shamsi TS
Asian Pac J Cancer Prev; 2015; 16(17):7415-23. PubMed ID: 26625737
[TBL] [Abstract][Full Text] [Related]
33. [MET/ERK and MET/JNK Pathway Activation Is Involved in BCR-ABL Inhibitor-resistance in Chronic Myeloid Leukemia].
Tsubaki M
Yakugaku Zasshi; 2018; 138(12):1461-1466. PubMed ID: 30504658
[TBL] [Abstract][Full Text] [Related]
34. Spotlight on imatinib mesylate in chronic myeloid leukemia.
Curran MP; Croom KF; Goa KL
BioDrugs; 2004; 18(3):207-10. PubMed ID: 15161340
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.
Lang AS; Mounier M; Roques M; Chretien ML; Boulin M
J Clin Pharm Ther; 2015 Aug; 40(4):391-7. PubMed ID: 25865674
[TBL] [Abstract][Full Text] [Related]
36. Sex correlates with differences in long-term outcome in chronic myeloid leukaemia patients treated with imatinib.
Breccia M; Colafigli G; Molica M; De Angelis F; Quattrocchi L; Latagliata R; Mancini M; Diverio D; Alimena G
Br J Haematol; 2016 Jun; 173(6):945-6. PubMed ID: 26304741
[No Abstract] [Full Text] [Related]
37. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
[TBL] [Abstract][Full Text] [Related]
38. Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report.
Patel M; Dukes IA; Hull JC
Am J Obstet Gynecol; 1991 Sep; 165(3):565-6. PubMed ID: 1892181
[TBL] [Abstract][Full Text] [Related]
39. Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.
Bonifacio M; Binotto G; Maino E; Calistri E; Marin L; Scaffidi L; Frison L; De Marchi F; Krampera M; Semenzato G; Fanin R; Ambrosetti A; Tiribelli M;
Haematologica; 2015 Aug; 100(8):e299-301. PubMed ID: 25820333
[No Abstract] [Full Text] [Related]
40. A newborn with teratogenic effect of imatinib mesylate: a very rare case report.
Jain N; Sharma D; Agrawal R; Jain A
Med Princ Pract; 2015; 24(3):291-3. PubMed ID: 25896670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
